Cognitive-behavioral changes in amyotrophic lateral sclerosis: Screening prevalence and impact on patients and caregivers

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 17, Issue 5-6, 2016, Pages 366-373

  Bock, Meredith ^a   Duong, Y Nhy ^b   Kim, Anthony ^b   Allen, Isabel ^b   Murphy, Jennifer ^b   Lomen Hoerth, Catherine ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyotrophic lateral sclerosis; caregiver burden; frontotemporal dementia; quality of life

Indexed keywords

ANTIDEPRESSANT AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; APATHY; ARTICLE; BEHAVIOR CHANGE; CAREGIVER; CAREGIVER BURDEN; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FORCED VITAL CAPACITY; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCREENING; AGED; COGNITION DISORDERS; COMPLICATION; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CAREGIVERS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84962106188     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2016.1165257     Document Type: Article

References (42)

1. F.Geser, V.M.Lee, J.Q.Trojanowski Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology. 2010;30:103–12.
2. C.Lomen-Hoerth Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord. 2004;17:337–41.
3. J.Murphy, R.Henry, C.Lomen-Hoerth Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:330–4.
4. M.Neumann, D.M.Sampathu, L.K.Kwong, A.C.Truax, M.C.Micsenyi, T.T.Chou,. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
5. C.M.Wilson, G.M.Grace, D.G.Munoz, B.P.He, M.J.Strong Cognitive impairment in sporadic ALS: a pathologic continuum underlying a multisystem disorder. Neurology. 2001;57:651–7.
6. D.Neary, J.S.Snowden, D.M.Mann Cognitive change in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci. 2000;180:15–20.
7. M.J.Strong, C.Lomen-Hoerth, R.J.Caselli, E.H.Bigio, W.Yang Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol. 2003;54 (Suppl 5):S20–3.
8. O.Hardiman, A.Hickey, L.J.O'Donerty Physical decline and quality of life in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:230–4.
9. H.Mitsumoto, M.Del Bene Improving the quality of life for people with ALS: the challenge ahead. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:329–36.
10. R.G.Miller, C.E.Jackson, E.J.Kasarskis, J.D.England, D.Forshew, W.Johnston,. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227–33.
11. L.H.Goldstein, S.Abrahams Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
12. A.R.Roach, A.J.Averill, S.C.Segerstrom, E.J.Kasarskis The dynamics of quality of life in ALS patients and caregivers. Ann Behav Med. 2009;37:197–206.
13. Z.Simmons, B.A.Bremer, R.A.Robbins, S.M.Walsh, S.Fischer Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92.
14. F.Tramonti, P.Bongioanni, C.Di Bernardo, S.Davitti, B.Rossi Quality of life of patients with amyotrophic lateral sclerosis. Psychol Health Med. 2012;17:621–8.
15. R.A.Robbins, Z.Simmons, B.A.Bremer, S.M.Walsh, S.Fischer Quality of life in ALS is maintained as physical function declines. Neurology. 2001;56:442–4.
16. L.H.Goldstein, L.Atkins, P.N.Leigh Correlates of Quality of Life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:123–9.
17. A.Chio, A.Vignola, E.Mastro, A.D.Giudici, B.Iazzolino, A.Calvo,. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol. 2010;17:1298–303.
18. P.Lillo, E.Mioshi, J.R.Hodges Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients' behavioral changes than physical disability: a comparative study. BMC Neurol. 2012;12:156.
19. B.R.Brooks, R.G.Miller, M.Swash, T.L.Munsat El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
20. S.C.Woolley, M.K.York, D.H.Moore, A.M.Strutt, J.Murphy, P.E.Schulz,. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010;11:303–11.
21. S.Abrahams, P.N.Leigh, A.Harvey, G.N.Vythelingum, D.Grise, L.H.Goldstein Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734–47.
22. C.Lomen-Hoerth, J.Murphy, S.Langmore, J.H.Kramer, R.K.Olney, B.Miller Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094–7.
23. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol. 1996;53:141–7.
24. J.A.Yesavage Geriatric Depression Scale. Psychopharmacol Bull. 1988;24:709–11.
25. J.S.Lou, A.Reeves, T.Benice, G.Sexton Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122–3.
26. A.Chio, A.Gauthier, A.Montuschi, A.Calvo, N.Di Vito, P.Ghiglione,. A cross-sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry. 2004;75:1597–601.
27. J.S.Lou, D.Moore, P.H.Gordon, R.Miller Correlates of quality of life in ALS: lessons from the minocycline study. Amyotroph Lateral Scler. 2010;11:116–21.
28. S.Elmstahl, B.Malmberg, L.Annerstedt Caregiver's burden of patients three years after stroke assessed by a novel caregiver burden scale. Arch Phys Med Rehabil. 1996;77:177–82.
29. P.A.Harris, R.Taylor, R.Thielke, J.Payne, N.Gonzalez, J.G.Conde Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.
30. M.L.Levy, B.L.Miller, J.L.Cummings, L.A.Fairbanks, A.Craig Alzheimer's disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol. 1996;53:687–90.
31. A.Kubler, S.Winter, A.C.Ludolph, M.Hautzinger, N.Birbaumer Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182–93.
32. A.Pizzimenti, M.Aragona, E.Onesti, M.Inghilleri Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28:115–19.
33. M.L.Levy, J.L.Cummings, L.A.Fairbanks, D.Masterman, B.L.Miller, A.H.Craig,. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998;10:314–9.
34. R.van Reekum, D.T.Stuss, L.Ostrander Apathy: why care? J Neuropsychiatry Clin Neurosci. 2005;17:7–19.
35. P.H.Gordon, Y.Wang, C.Doorish, M.Lewis, V.Battista, H.Mitsumoto,. A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler. 2007;8:362–5.
36. L.H.Goldstein, M.Adamson, L.Jeffrey, K.Down, T.Barby, C.Wilson,. The psychological impact of MND on patients and carers. J Neurol Sci. 1998;160 (Suppl 1):S114–21.
37. E.Mioshi, J.Caga, P.Lillo, S.Hsieh, E.Ramsey, E.Devenney,. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology. 2014;82:149–55.
38. E.Mioshi, C.McKinnon, S.Savage, C.M.O'Connor, J.R.Hodges Improving burden and coping skills in frontotemporal dementia caregivers: a pilot study. Alzheimer Dis Assoc Disord. 2013;27:84–6.
39. E.D.Huey, K.T.Putnam, J.Grafman A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66:17–22.
40. M.Manoochehri, E.D.Huey Diagnosis and management of behavioral issues in frontotemporal dementia. Curr Neurol Neurosci Rep. 2012;12:528–36.
41. O.Piguet, M.Hornberger, E.Mioshi, J.R.Hodges Behavioral-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 2011;10:162–72.
42. J.F.-L.P.Murphy, R.Goetz, C.Lomen Hoerth,. Cognitive behavioral Screening Reveals Prevalent Impairment in a Large Multicenter ALS Cohort. Neurology. 2015;In press.